Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Vaxcyte Inc (NASDAQ: PCVX) closed at $29.9 down -0.37% from its previous closing price of $30.01. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 1.96 million shares were traded. PCVX stock price reached its highest trading level at $30.2749 during the session, while it also had its lowest trading level at $29.3.
Ratios:
For a deeper understanding of Vaxcyte Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.11 and its Current Ratio is at 11.11. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.Mizuho initiated its Buy rating on December 07, 2023, with a $69 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 3881707776 and an Enterprise Value of 2306136320.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.05, which has changed by -0.61715746 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -13.09%, while the 200-Day Moving Average is calculated to be -52.41%.
Shares Statistics:
For the past three months, PCVX has traded an average of 1.64M shares per day and 1287560 over the past ten days. A total of 129.82M shares are outstanding, with a floating share count of 125.99M. Insiders hold about 2.95% of the company’s shares, while institutions hold 113.39% stake in the company. Shares short for PCVX as of 1752537600 were 13618625 with a Short Ratio of 8.31, compared to 1749772800 on 13703103. Therefore, it implies a Short% of Shares Outstanding of 13618625 and a Short% of Float of 11.83.
Earnings Estimates
The stock of Vaxcyte Inc (PCVX) is currently in the spotlight, with 5.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$1.36, with high estimates of -$1.05 and low estimates of -$1.71.
Analysts are recommending an EPS of between -$4.34 and -$5.96 for the fiscal current year, implying an average EPS of -$5.1. EPS for the following year is -$5.97, with 5.0 analysts recommending between -$4.16 and -$7.28.
